Literature DB >> 15710323

"Dub"bing a tumor suppressor pathway.

Wojciech Niedzwiedz1, Ketan J Patel.   

Abstract

The autosomal recessive disease Fanconi anemia (FA) causes bone marrow failure and a hugely increased propensity to develop cancer. Cells from FA patients are prone to chromosome breakage, indicating that FA gene products are required to ensure genomic integrity. Most of the identified FA proteins are components of a nuclear complex whose principal function is to activate FANCD2 by monoubiquitination. Monoubiquitinated FANCD2 accumulates at sites of genome damage, where it probably functions to facilitate DNA repair. A recent paper in Molecular Cell (Nijmanet al., 2005) reports the identification of an enzyme that is responsible for regulating the FA pathway by deactivating FANCD2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710323     DOI: 10.1016/j.ccr.2005.01.018

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  2 in total

1.  The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.

Authors:  Jayoung Kim; Wun-Jae Kim; Zhiqian Liu; Massimo Loda; Michael R Freeman
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

2.  FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth.

Authors:  Jun Zhang; Deping Zhao; Hwan Ki Park; Hong Wang; Roy B Dyer; Wanguo Liu; George G Klee; Mark A McNiven; Donald J Tindall; Julian R Molina; Peiwen Fei
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.